Xxera/openscience/retractions

Record #20542

In Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells

Girija Dasmahapatra, Hiral Patel, Johnathan Friedberg, Steven N Quayle, Simon S Jones, Steven Grant

Journal

Molecular Cancer Therapeutics

Publisher

American Association for Cancer Research

Original paper date

Sep 19, 2014

Original DOI

10.1158/1535-7163.MCT-14-0220

Country

🇺🇸 United States

Institution

Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia · James T. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York · Department of Medicine, University of Rochester Medical Center, Rochester, New York · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York · Acetylon Pharmaceuticals Inc., Boston, Massachusetts · Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia · Virginia Institute of Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia

Open access

No

Article type

Research Article

Broad categories

(BLS) Biochemistry (BLS) Biology - Cancer (BLS) Biology - Cellular (BLS) Toxicology (HSC) Medicine - Oncology

Citation lifecycle

How this paper is being cited

Pre-retraction

29

Same day

0

Post-retraction

6

% post-retraction

17.1%

~6.2 citations/yr before retraction · ~0.8 citations/yr after

— citing papers

Who is still citing this work

Loading…